NLRP3 and COVID-19: Under certain cardiovascular conditions, the inflammatory response triggered by the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activation leads to hyperinflammation, which promotes cardiac injury and could be targeted for the treatment of COVID-19.209